Mankind Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,660.00
30 (1.14%)
BSENSE

Nov 20

BSE+NSE Vol: 4.74 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,660.00",
    "chg": 30,
    "chgp": "1.14%",
    "dir": 1,
    "prev_price": "2,630.00",
    "mcapval": "109,213.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE634S01028",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "4.74 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4268588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4268588.png",
        "date": "2026-11-19 15:01:18",
        "description": "Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential shifts in investor positioning. Despite trading within a narrow price range and underperforming its sector marginally, the stock’s derivatives activity suggests heightened directional bets as it nears its 52-week high."
      },
      {
        "title": "Mankind Pharma Gains 4.49%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-gains-449-3-key-factors-driving-the-weeks-momentum-4261552",
        "imagepath": "",
        "date": "2026-11-14 11:00:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> New 52-week high (Rs.2,685)</p>\n                    <p><strong>Nov 09:</strong> Surge in call option activity</p>\n                    <p><strong>Nov 09:</strong> Sharp open interest increase in derivatives</p>\n                    <p><strong>Nov 12:</strong> Technical momentum shifts amid mixed signals</p>\n                    <p><strong>Nov 13:</strong> Week closes at Rs.2,654 (+4.49%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,540.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bullish-momentum-4257019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4257019.png",
        "date": "2026-11-09 15:00:16",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock recently hit a new 52-week high of Rs 2,663, supported by strong volume and positive price action, reflecting growing investor confidence in this mid-cap pharmaceutical player."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bullish-momentum-4256975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4256975.png",
        "date": "2026-11-09 14:00:15",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and potential directional bets. The stock’s recent price action, combined with robust volume and improving mojo scores, suggests growing investor confidence in the pharmaceuticals & biotechnology sector."
      },
      {
        "title": "Mankind Pharma Ltd Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-ltd-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4256956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4256956.png",
        "date": "2026-11-09 13:00:11",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock, trading close to its 52-week high, has outperformed its sector and demonstrated robust volume and price action, reflecting growing investor confidence in the pharmaceuticals and biotechnology space."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bullish-momentum-4256925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4256925.png",
        "date": "2026-11-09 12:00:11",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock recently hit a new 52-week high of Rs 2,644.4, supported by robust volume and positive price action, reflecting growing investor confidence in the mid-cap pharmaceutical player."
      },
      {
        "title": "Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Bullish Market Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-ltd-sees-sharp-open-interest-surge-amid-bullish-market-momentum-4256885",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4256885.png",
        "date": "2026-11-09 11:00:12",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved mojo ratings, suggests growing investor confidence in this mid-cap pharmaceutical player."
      },
      {
        "title": "11,607 Call Contracts Traded on Mankind Pharma Ltd as Stock Rallies 6.5% in Three-Day Streak",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-sees-surge-in-call-option-activity-amid-bullish-momentum-4256898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_most_active_stocks_calls_4256898.png",
        "date": "2026-11-09 11:00:11",
        "description": "11,607 call contracts on Mankind Pharma Ltd changed hands on 09 Nov 2026, coinciding with a 3.18% gain in the stock price to close at Rs 2,662.70. The options activity clustered around the Rs 2,700 strike price, just slightly out-of-the-money relative to the underlying, signalling a speculative but near-term directional bet."
      },
      {
        "title": "Mankind Pharma Ltd Sees Significant Open Interest Surge Amid Bullish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mankind-pharma-ltd-sees-significant-open-interest-surge-amid-bullish-momentum-4256530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MankindPharmaLt_oi_spurts_by_underlying_4256530.png",
        "date": "2026-11-09 10:00:07",
        "description": "Mankind Pharma Ltd (MANKIND) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price action, coupled with increased volumes and a notable upgrade in its Mojo Grade to Buy, underscores growing investor confidence in this mid-cap pharmaceutical player."
      }
    ],
    "total": 191,
    "sid": "1003845",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "19-Nov-2026",
      "details": "Please find attached intimation regarding allotment of 38442 equity shares pursuant to ESOP Plan",
      "source": "BSE"
    },
    {
      "caption": "Change In Corporate Office Address Of RTA",
      "datetime": "13-Nov-2026",
      "details": "Please find attached intimation regarding change in Corporate Office Address of RTA",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Nov-2026",
      "details": "Please find attached Intimation of participation in the Investor Conference",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

19-Nov-2026 | Source : BSE

Please find attached intimation regarding allotment of 38442 equity shares pursuant to ESOP Plan

Change In Corporate Office Address Of RTA

13-Nov-2026 | Source : BSE

Please find attached intimation regarding change in Corporate Office Address of RTA

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-Nov-2026 | Source : BSE

Please find attached Intimation of participation in the Investor Conference

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Mankind Pharma Ltd has declared 100% dividend, ex-date: 08 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available